Clinical Trials List
Protocol NumberVE303-003
Not yet recruiting
2025-04-01 - 2027-11-30
Recruiting3
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Puo-Hsien Le Division of Infectious Disease
- 陳建彰 Division of Infectious Disease
- Chia-Jung Kuo Division of Infectious Disease
- 鄭鈞文 Division of Infectious Disease
- Po-Yan Huang Division of Infectious Disease
- Ting-Shu Wu Division of Infectious Disease
- Nan-Yu Chen Division of Infectious Disease
- 謝顯森 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ho Mao-Wang Division of Infectious Disease
- 蘇浤傑 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 呂其融 Division of Infectious Disease
- Wen-Hung Hsu Division of Infectious Disease
- Shang-Yi Lin Division of Infectious Disease
- Chung-Hao Huang Division of Infectious Disease
- Chun-Yuan Lee Division of Infectious Disease
- Tun-Chieh Chen Division of Infectious Disease
- Fang-Jung Yu Yu Division of Infectious Disease
- Chun-Yu Lin Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
852 participants
